why choose us

Clinical Trials Search

Showing 18,500 of 132,963 result(s)
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Status: Completed

Condition: Metastatic Prostate Cancer

Interventions: Tablet administered orally, per protocol, 2 x daily.
Darolutamide is an orally administered molecular drug therapy that blocks the action of test

Date: 2022-11-08

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

Status: Completed

Condition: Corneal Edema

Interventions: Intracameral injection of magnetic human corneal endothelial cells (EO2002)

Date: 2022-11-08

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Status: Completed

Condition: Systemic Lupus Erythematosus

Interventions: Specified dose on specified days

Date: 2022-11-08

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

Status: Completed

Condition: Corneal Edema

Interventions: DEXTENZA 0.4Mg Ophthalmic Insert is a corticosteroid (to decrease inflammation) intracanalicular insert placed in the punctum, a natural opening in th

Date: 2022-11-08

Cancer Prevention for Young Rural Adults

Status: NOT_YET_RECRUITING

Condition: Cancer

Interventions: Participants, aged 18-26, will join a private Facebook group to participate in the intervention.
The group is not viewable to the public, includi

Date: 2022-11-08

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

Status: Completed

Condition: Wounds and Injuries

Interventions: Participants will receive Low Titer O Whole Blood administered intravenously or intraosseously.

Date: 2022-11-08

Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)

Status: Completed

Condition: Sickle Cell Disease

Interventions: Motixafortide is to be administered as a subcutaneous injection at a dose of 1.25 mg;kg

Date: 2022-11-08

Birth to Three - Cavity Free

Status: Completed

Condition: Caries,Dental

Interventions: SDT is relatively unique among theories of motivation due to its focus on the quality, rather than the quantity, of motivation.
Central to SDT is

Date: 2022-11-08

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Status: COMPLETED

Condition: Metastatic Prostate Cancer
Non-metastatic Prostate Cancer
Prostate Cancer

Interventions: DRUG: Darolutamide - Tablet administered orally, per protocol, 2 x daily. Darolutamide is an orally administered molecular drug therapy that blocks th

Date: 2022-11-08